Allianz Asset Management Gmb H Enzo Biochem Inc Transaction History

Allianz Asset Management Gmb H

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$5.06 - $6.78 $1.55 Million - $2.07 Million	-305,383 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$5.43 - $8.36 $504,756 - $777,120	-92,957 Reduced 23.34%	305,383 $1.67 Million
Q4 2017 Feb 13, 2018	SELL	$8.15 - $10.55 $169,495 - $219,408	-20,797 Reduced 4.96%	398,340 $3.25 Million
Q3 2017 Nov 13, 2017	BUY	$10.45 - $11.44 $763,518 - $835,852	73,064 Added 21.11%	419,137 $4.39 Million
Q2 2017 Aug 14, 2017	BUY	N/A	326,445 Added 1663.16%	346,073 $3.82 Million
Q1 2017 Apr 17, 2019	BUY	N/A	19,628	19,628 $164,000

15.5M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $50.2M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.